Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Molecular Monitoring of Residual Disease (MRD) during Induction and Intensification Phases in Low Risk Adult B Cell ALL Treated According to the MRC UKALL12 Protocol.

Letizia Foroni, MD, PhD, Wayne Mitchell, PhD, Lena J. Rai, Anouska Casanova, Gareth Gerrard, Bella Patel, Sue Richards, Adele Fielding, Anthony H. Goldstone

Blood (2005) 106 (11): 1466.

https://doi.org/10.1182/blood.V106.11.1466.1466

Published: 2005

Journal Articles

The Value of Molecular Monitoring for Residual Disease (MRD) in Early Morphological Remitters among Adults Diagnosed with B Cell ALL and Treated According to the MRC UKALL12 Protocol.

Letizia Foroni, MD, PhD, Wayne Mitchell, PhD, Lena J. Rai, Sue Richards, Adele Fielding, Anthony H. Goldstone

Blood (2005) 106 (11): 1467.

https://doi.org/10.1182/blood.V106.11.1467.1467

Published: 2005

Journal Articles

Value of Molecular Monitoring for Minimal Residual Disease Preceding Autologous SCT Following Diagnosis of B Cell Acute Lymphoblastic Leukemia in Patients Treated with the MRC UKALL12 Protocol.

Letizia Foroni, MD, PhD, Wayne Mitchell, PhD, Lena J. Rai, Anouska Casanova, Bella Patel, MD, Sue Richards, Adele Fielding, MD, Anthony H. Goldstone

Blood (2005) 106 (11): 1468.

https://doi.org/10.1182/blood.V106.11.1468.1468

Published: 2005

Journal Articles

Sequential Quantitative Minimal Residual Disease in BCR-ABL Positive Acute Lymphoblastic Leukaemia: Differential Observations between Major and Minor Fusion Gene Rearrangements and Variation Due to Source Material.

Gareth Gerrard, MSc, Wayne Mitchell, PhD, Anthony Goldstone, MD, Raj Chopra, MD, PhD, Georgina Buck, PhD, Sue Richards, DPhil, Letizia Foroni, MD, PhD

Blood (2004) 104 (11): 1093.

https://doi.org/10.1182/blood.V104.11.1093.1093

Published: 2004

Journal Articles

Cyclin-C: Analysis of a Candidate Tumour Suppressor Genes on 6q15-q21 in Malignant Lymphoid Cell Lines and Lymphoid Acute Leukemias.

Paul B. Sinclair, PhD, Wayne Mitchell, PhD, Jaspal Kaeda, PhD, Letizia Foroni, MD, PhD

Blood (2004) 104 (11): 4332.

https://doi.org/10.1182/blood.V104.11.4332.4332

Published: 2004

NARROW

Molecular Monitoring of Residual Disease (MRD) during Induction and Intensification Phases in Low Risk Adult B Cell ALL Treated According to the MRC UKALL12 Protocol.

The Value of Molecular Monitoring for Residual Disease (MRD) in Early Morphological Remitters among Adults Diagnosed with B Cell ALL and Treated According to the MRC UKALL12 Protocol.

Value of Molecular Monitoring for Minimal Residual Disease Preceding Autologous SCT Following Diagnosis of B Cell Acute Lymphoblastic Leukemia in Patients Treated with the MRC UKALL12 Protocol.

Sequential Quantitative Minimal Residual Disease in BCR-ABL Positive Acute Lymphoblastic Leukaemia: Differential Observations between Major and Minor Fusion Gene Rearrangements and Variation Due to Source Material.

Cyclin-C: Analysis of a Candidate Tumour Suppressor Genes on 6q15-q21 in Malignant Lymphoid Cell Lines and Lymphoid Acute Leukemias.

Email alerts

ASH Publications

American Society of Hematology

Molecular Monitoring of Residual Disease (MRD) during Induction and Intensification Phases in Low Risk Adult B Cell ALL Treated According to the MRC UKALL12 Protocol.

The Value of Molecular Monitoring for Residual Disease (MRD) in Early Morphological Remitters among Adults Diagnosed with B Cell ALL and Treated According to the MRC UKALL12 Protocol.

Value of Molecular Monitoring for Minimal Residual Disease Preceding Autologous SCT Following Diagnosis of B Cell Acute Lymphoblastic Leukemia in Patients Treated with the MRC UKALL12 Protocol.

Sequential Quantitative Minimal Residual Disease in BCR-ABL Positive Acute Lymphoblastic Leukaemia: Differential Observations between Major and Minor Fusion Gene Rearrangements and Variation Due to Source Material.

Cyclin-C: Analysis of a Candidate Tumour Suppressor Genes on 6q15-q21 in Malignant Lymphoid Cell Lines and Lymphoid Acute Leukemias.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only